We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Simple Urine Test Could Detect Multiple Cancers at Early Stage

By LabMedica International staff writers
Posted on 25 Jun 2025

When disease is present, the human body releases tiny molecules known as volatile organic compounds (VOCs). More...

Now, a spectroscopy and artificial intelligence (AI)-powered urine-based test uses scent-based technology for the routine and noninvasive detection of cancer-related VOCs.

TOBY, Inc. (New York City, NY, USA) has developed a single urine test that detects 10 cancers, representing over 60% of all new cases globally. This test identifies the unique molecular signature of cancer by combining the precision of spectroscopy, changes in biomarkers (VOCs), and cutting-edge computational algorithms to deliver early, easy, and affordable cancer screening. The process begins with spectroscopy, analyzing the molecular signature of VOCs in urine. These signatures reflect real-time changes in physiology and metabolism. The company’s proprietary AI interprets this complex data to identify early patterns of disease, often before symptoms appear. These algorithms are the result of deep research, development, and training on diverse biological signatures. Every model is engineered to learn from high-dimensional data, capturing subtle, disease-specific patterns with remarkable precision.

Unlike traditional diagnostics that rely on imaging or genetic sequencing, this test focuses on what the body emits in the moment. This approach is fast, scalable, and noninvasive—offering a new pathway for early detection across multiple cancer types. Instead of just detecting cancer, the test interprets the body’s chemical signals using a single, simple urine sample and turns them into actionable insights. TOBY combine truly noninvasive sampling, advanced spectroscopy, and AI for a uniquely accurate, accessible cancer test for multiple cancers.

"Our goal is to support earlier detection, when treatment is most effective and the burden on patients and the healthcare system is reduced," said Dragan Sebišanović, Chief Science Officer of TOBY. "Our technology uses machine learning to help identify molecular patterns associated with early-stage cancer."

Related Links:
TOBY, Inc.


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
Sample Transportation System
Tempus1800 Necto
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: The partnership between OGT and QIAGEN unlocks a complete sample to report workflow for SureSeq NGS panels (Photo courtesy of OGT)

Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation

In clinical research, next-generation sequencing (NGS) panels provide essential insights for genetic analysis, but many laboratories face challenges in transforming raw sequencing data into clinically... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.